Sotrovimab-resistant covid ‘could spread’
From The Medical Republic, 10 March 2022: Covid can develop resistance to the monoclonal antibody that was thought to be “variant-proof”, Australian research suggests. A research letter published in the New England Journal of Medicine reports on four patients with covid who experienced treatment failure with sotrovimab, and were then found to have variants of … Continue reading Sotrovimab-resistant covid ‘could spread’